|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.695 USD | +7.80% |
|
+7.97% | -18.13% |
| 05-15 | Moleculin Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-13 | Moleculin Biotech Inc - to unblind Miracle trial data before June 30, 2026 - SEC filing | RE |
147dd7600aa2cab6ae87e6.tRnSC_mVs5nj6oCzhT5IOYnnIy8LugGDybB7uJBpmH4.xXuUU5Kh1a2Ch_H90FE7VLmwe05S_VjKoOdD-agD0wbabptjt9vl0Ia_7w~94982c6e3d07ce2a3448e1b6cab23d73
Select your edition
All financial news and data tailored to specific country editions
